EGRX  valuation analysis

Basics
Name: Eagle Pharmaceuticals Inc
Description: Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 09, 2022
Market cap: $580.68M (1335th)
Sales(TTM): $246.17M (1345th)
Earnings(TTM): $50.69M (1122nd)

Value
FFER: 0.59*
Actual price: $44.99
* Earnings were reported Aug 08, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Eagle Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry